Hantaviruses in Estonia

Journal of Medical Virology
I GolovljovaA Lundkvist

Abstract

Human serum samples collected from healthy individuals in 14 counties were screened by ELISA in order to investigate the presence of hantavirus infections in Estonia. Out of 1,234 serum samples, 124 were found positive for hantavirus-specific IgG and were subsequently serotyped by a focus reduction neutralization test. A total of 112 samples neutralized at least one of the examined hantaviruses-Puumala (PUUV), Saaremaa (SAAV), Dobrava (DOBV), Hantaan, and Seoul viruses-and thereby, the focus reduction neutralization test confirmed the overall hantavirus seroprevalence rate in Estonia to be 9.1%. Most of the sera showed a specific reaction (at least 4-fold higher endpoint titer) of neutralizing antibodies to PUUV (5.1%), while 3.4% showed a SAAV- or SAAV/DOBV-specific reaction. The fact that seven sera (0.6%) could not be serotyped may indicate the presence of an unknown hantavirus serotype. Hantavirus infections were confirmed in 13 of 14 investigated counties, with highly varying seroprevalence rates (1.0-28.4%). The sex ratio was 1.8:1.0 (M:F), and the antibody prevalence peaked in the age group 45-54 years. A total of 513 rodents of seven species trapped in seven counties were examined for the presence of hantavirus antigen,...Continue Reading

References

Mar 1, 1978·The Journal of Infectious Diseases·H W LeeK M Johnson
Oct 1, 1992·Journal of Medical Virology·T Avsic-ZupancJ W LeDuc
Dec 1, 1991·The American Journal of Tropical Medicine and Hygiene·B NiklassonE Tkachenko
Feb 1, 1987·The Journal of Infectious Diseases·B Niklasson, J W LeDuc
Dec 1, 1987·The Journal of Infectious Diseases·T W LimH W Lee
May 1, 1988·The American Journal of Tropical Medicine and Hygiene·E O NuzumJ W LeDuc
Nov 1, 1982·The Journal of Infectious Diseases·H W LeeK M Johnson
Mar 1, 1981·The American Journal of Tropical Medicine and Hygiene·H W LeeR S Foulke
Apr 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L ZöllerM Roggendorf
Apr 1, 1995·Epidemiology and Infection·J GroenA D Osterhaus
Feb 1, 1995·Journal of Clinical Microbiology·J HörlingB Niklasson
Apr 23, 1994·Lancet·M G Papadimitriou, A Antoniadis
Dec 1, 1994·Journal of Virology·A PlyusninM Brummer-Korvenkontio
Oct 1, 1996·The Journal of General Virology·J HörlingB Niklasson
Apr 1, 1997·Emerging Infectious Diseases·C Schmaljohn, B Hjelle
Sep 23, 1997·Lancet·A LundkvistA Plyusnin
Oct 23, 1997·Journal of Medical Virology·M D BowenN Nowotny
Dec 17, 1997·Journal of Clinical Microbiology·K B SjölanderA Lundkvist
Jul 14, 1998·Journal of Medical Virology·A PapaA Antoniadis
Aug 26, 1998·Lancet·A LundkvistA Vaheri
Jan 29, 1999·Lancet·A PlyusninA Vaheri
Sep 11, 1999·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S W AberleF X Heinz
Sep 25, 1999·The American Journal of Tropical Medicine and Hygiene·C SiboldD H Krüger
Nov 27, 1999·Scandinavian Journal of Infectious Diseases·M Brummer-KorvenkontioA Vaheri
May 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T Avsic-ZupancA Lundkvist
Feb 24, 2001·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I GolovljovaA Lundkvist
Oct 30, 2001·Advances in Virus Research·A PlyusninA Lundkvist
Mar 16, 2002·Epidemiology and Infection·K B SjölanderA Lundkvist

❮ Previous
Next ❯

Citations

Jan 17, 2009·Medical Microbiology and Immunology·Marc MertensRainer G Ulrich
May 12, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Kirill NemirovAlexander Plyusnin
Oct 3, 2003·The Lancet Infectious Diseases·Olli VapalahtiAntti Vaheri
Aug 28, 2010·Vector Borne and Zoonotic Diseases·Gert E OlssonHeikki Henttonen
Jun 16, 2005·Journal of Clinical Microbiology·Boris KlempaDetlev H Krüger
Apr 7, 2006·Journal of Clinical Microbiology·Alexander PlyusninAke Lundkvist
May 28, 2003·Journal of Virology·Alexander PlyusninAke Lundkvist
Jan 26, 2008·Emerging Infectious Diseases·Irina GolovljovaAke Lundkvist
Jan 24, 2014·Viruses·Hanan Sheikh AliRainer G Ulrich
Nov 24, 2004·Microbiology and Immunology·Nandadeva LokugamageIkuo Takashima
May 9, 2008·Reviews in Medical Virology·Antti VaheriAlexander Plyusnin
Oct 27, 2009·Journal of Medical Virology·Angelina PlyusninaAlexander Plyusnin
Mar 4, 2009·Expert Review of Anti-infective Therapy·Paul HeymanTatjana Avsic-Zupanc
Dec 17, 2016·Emerging Infectious Diseases·Petra StrakováRainer G Ulrich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
A LundkvistV Kalnina
© 2021 Meta ULC. All rights reserved